Trump's drug order sparks concern for India's pharma policy: GTRI

Donald Trump's "Most Favored Nation" pricing rule, aimed at significantly lowering U.S. drug prices, is expected to have global repercussions. The move could pressure pharmaceutical companies to seek higher revenues in markets like India, potentially impacting its pharmaceutical policies.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/UXRAgN4
via IFTTT